Partners

Founded by brigham and women's hospital and massachusetts general hospital

Office of Continuing Professional Development

ASH 2018 Highlights

new DFBWCC logo.jpg

Saturday, January 12, 2019
7:30 a.m. - 2:15 p.m.

Boston Marriott Newton Hotel
2345 Commonwealth Avenue
Newton, MA 02466

Description

The care of patients with hematologic malignancies is evolving rapidly. This continuing medical education activity will discuss new developments in the diagnosis and treatment of hematologic malignancies, as presented at the 2018 Annual Meeting of the American Society of Hematology (ASH).

At this one-day course, faculty will share the latest updates in lymphoma, leukemia, multiple myeloma, coagulation disorders, and stem cell transplantation. Through case-based presentations and Q&A, attendees will gain a deeper understanding of emerging treatments available for blood cancers and blood disorders and learn how these new therapies can be integrated into daily practice.

Learning Objectives

At the conclusion of this course, attendees will be able to:

1. Provide an overview and highlight the recent medical advances presented at the 2018 Annual Meeting of the American Society of Hematology, which will help physicians achieve better patient outcomes.
2. Recognize appropriate management and treatment options for hematologic malignancies and utilize these approaches in routine clinical practice.
3. Recognize new therapies and approaches in non-malignant hematology.

Target Audience

This activity is directed toward hematologists, medical oncologists, internists, nurse practitioners, oncology nurses, and other interested healthcare providers.

Agenda

7:30 am

Registration Check-in and Continental Breakfast

8:00

Welcome and Introduction
Ann S. LaCasce, MD, MMSc

8:15

Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia (APL) &
Myelodysplastic Syndrome (MDS)
Richard M. Stone, MD

8:45

Lymphoma
Eric D. Jacobsen, MD

9:30

Multiple Myeloma
Omar Nadeem, MD

10:15

Break

10:30

Coagulation
Jean M. Connors, MD

11:15

Acute Lymphocytic Leukemia (ALL) and Chronic Myelogenous Leukemia (CML)
Daniel J. DeAngelo, MD, PhD

12:00 pm

Lunch

1:00

Chronic Lymphocytic Leukemia (CLL)
Matthew S. Davids, MD, MMSc

1:45

Stem Cell Transplantation
Corey S. Cutler, MD, MPH, FRCPC

2:10

Closing Remarks

2:15 pm

Adjourn

Please note: program changes/substitutions may be made without notice

Faculty

Ann S. LaCasce, MD, MMSc -Course Director
Director, Dana-Farber/Partners CancerCare Hematology-Medical Oncology Fellowship Program,
Medical Oncologist, Adult Lymphoma Program,
Dana-Farber/Brigham and Women's Cancer Center.
Associate Professor of Medicine,Harvard Medical School.

Jean M. Connors, MD
Medical Director, Anticoagulation Management Service,
Dana-Farber/Brigham and Women's Cancer Center.
Associate Professor of Medicine, Harvard Medical School.

Corey S. Cutler, MD, MPH, FRCPC
Director, Stem Cell Transplant Survivorship Clinic,
Dana-Farber/Brigham and Women's Cancer Center.
Associate Professor of Medicine, Harvard Medical School.

Matthew S. Davids, MD, MMSc
Associate Director, Center for Chronic Lymphocytic Leukemia,
Dana-Farber/Brigham and Women's Cancer Center.
Assistant Professor of Medicine, Harvard Medical School.

Daniel J. DeAngelo, MD, PhD
Director, Clinical and Translational Research,
Adult Leukemia Program,
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Medicine,
Harvard Medical School.

Eric D. Jacobsen, MD
Clinical Director, Adult Lymphoma Program,
Director, Histiocyte Disorders Center,
Dana-Farber/Brigham and Women's Cancer Center.
Assistant Professor of Medicine, Harvard Medical School.

Jacob Laubach, MD, MPP
Clinical Director, Jerome Lipper Multiple Myeloma Center,
Dana-Farber/Brigham and Women's Cancer Center.
Assistant Professor of Medicine, Harvard Medical School.

Omar Nadeem, MD
Instructor in Medicine, Harvard Medical School;
Attending Physician, Jerome Lipper Multiple Myeloma Center,
Dana-Farber Cancer Institute

Richard M. Stone, MD
Chief of Staff, Dana-Farber Cancer Institute.
Director, Translational Research, Adult Leukemia Program,
Dana-Farber/Brigham and Women's Cancer Center.
Professor of Medicine, Harvard Medical School.

About the Center for Hematologic Oncology at Dana-Farber/Brigham and Women's Cancer Center

We offer advanced, specialized care for patients with all types of hematologic malignancies, including leukemia and similar bone marrow disorders, lymphoma, multiple myeloma, Waldenstrom's macroglobulinemia, and other related blood disorders.

Dana-Farber/Brigham and Women's Cancer Center is at the forefront of stem cell transplantation, performing more than 500 transplants each year. Our team of specialists are national leaders in basic and clinical research designed to bring cutting-edge, innovative therapies to patients with blood cancers. The program is committed to working closely with referring oncologists to jointly devise clinical strategies to improve the care of our patients.

Registration Fees

Registration Fee:
(non-refundable, includes course materials, continental breakfast, lunch, and complimentary parking):

- $75.00 through December 30, 2018
- $85.00afterDecember 30, 2018


Forms of Payment Accepted:

- Credit Card: Online
- Check: Mail-in/On-site

(Please note-: cash is not accepted)

Contact

For questions regarding registration or CME information, please contact the Partners Office of Continuing Professional Development atpartnerscpd@partners.org or 857-282-2515.

For questions regarding the conference, please call 1-800-553-3787.

If you have any food allergies, or if you require accommodations such as an ASL interpreter, materials in an alternative format, or wheelchair access, please contact our course coordinator atkwooten@partners.org or call 1-800-553-3787 before the live event.

Location and Parking

This course will be held at the Boston Marriott Newton Hotel, 2345 Commonwealth Avenue, Newton, MA.

Provided by

Dana-Farber/Brigham and Women's Cancer Center and Partners HealthCare System

new DFBWCC logo.jpg

CME Information

ACCREDITATION

Physician Credits:
Partners HealthCare System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Partners HealthCare System designates this live activity for a maximum of 5AMA PRA Category 1 CreditsTM.Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Nursing Credits:
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under provider number CEP 5832 to award 5.0 continuing education contact hours through the California Board of Registered Nursing. Approval Period: December 2017-December 2020.

LLS maintains responsibility for the program. Upon completion of this program and submission of the activity evaluation, a certificate of completion will be
provided to you within 30 days.

Privacy Statement

This website uses Echo360 technologies. Echo360 partners with the world’s leading educational institutions and industry associations to enhance the teaching and learning experience for students and professionals like you. Our goal is to enable a more engaging and successful learning experience by providing you with live and on-demand access to study tools, videos, and collaboration capabilities in an online classroom to help you achieve your educational goals. We believe you should always know what data we collect from you and how we use it. As part of our ongoing commitment to transparency, and to support new European data protection laws, we're updating our Privacy Policy to inform you about the information that you share with us. The revised policy will take effect on May 25, 2018. By using our services on or after that date, you'll be agreeing to these updates. We encourage you to read this document in full. Echo360, Inc. 11955 Freedom Drive, Suite 700, Reston, VA 20190 USA